Sangeeta N. Bhatia insider trades: Vertex Pharmaceuticals Inc / Ma (VRTX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Sangeeta reports to the SEC
Open-market buys and sales
27 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 4, 2026 | VRTX | ↓ Sell | 318 | $423.73 | $135K | Direct | May 5, 2026 (1d) |
| Feb 13, 2026 | VRTX | ↓ Sell | 266 | $500.00 | $133K | Direct | Feb 18, 2026 (5d) |
| Aug 27, 2025 | VRTX | ↓ Sell | 266 | $386.69 | $103K | Direct | Aug 29, 2025 (2d) |
| May 2, 2025 | VRTX | ↓ Sell | 400 | $505.86 | $202K | Direct | May 5, 2025 (3d) |
| Aug 30, 2024 | VRTX | ↓ Sell | 646 | $500.00 | $323K | Direct | Sep 4, 2024 (5d) |
| Aug 8, 2024 | VRTX | ↓ Sell | 1,292 | $466.29 | $602K | Direct | Aug 12, 2024 (4d) |
| May 2, 2024 | VRTX | ↓ Sell | 467 | $402.95 | $188K | Direct | May 3, 2024 (1d) |
| Oct 17, 2023 | VRTX | ↓ Sell | 243 | $375.00 | $91K | Direct | Oct 19, 2023 (2d) |
| Oct 6, 2023 | VRTX | ↓ Sell | 242 | $360.00 | $87K | Direct | Oct 11, 2023 (5d) |
| Aug 9, 2023 | VRTX | ↓ Sell | 242 | $345.51 | $84K | Direct | Aug 11, 2023 (2d) |
| May 2, 2023 | VRTX | ↓ Sell | 580 | $348.28 | $202K | Direct | May 3, 2023 (1d) |
| Oct 24, 2022 | VRTX | ↓ Sell | 621 | $310.00 | $193K | Direct | Oct 26, 2022 (2d) |
| Aug 8, 2022 | VRTX | ↓ Sell | 621 | $293.03 | $182K | Direct | Aug 10, 2022 (2d) |
| Jul 29, 2022 | VRTX | ↓ Sell | 621 | $278.77 | $173K | Direct | Aug 2, 2022 (4d) |
| May 2, 2022 | VRTX | ↓ Sell | 737 | $258.94 | $191K | Direct | May 4, 2022 (2d) |
| Apr 8, 2022 | VRTX | ↓ Sell | 1,907 | $280.20 | $534K | Direct | Apr 12, 2022 (4d) |
| Jun 2, 2021 | VRTX | ↓ Sell | 559 | $209.69 | $117K | Direct | Jun 4, 2021 (2d) |
| Oct 5, 2020 | VRTX | ↓ Sell | 10,516 | $266.79 | $2.8M | Direct | Oct 7, 2020 (2d) |
| Jun 2, 2020 | VRTX | ↓ Sell | 952 | $282.88 | $269K | Direct | Jun 3, 2020 (1d) |
| Nov 1, 2019 | VRTX | ↓ Sell | 1,291 | $200.00 | $258K | Direct | Nov 4, 2019 (3d) |
| Oct 2, 2019 | VRTX | ↓ Sell | 8,379 | $166.80 | $1.4M | Direct | Oct 4, 2019 (2d) |
| Jun 3, 2019 | VRTX | ↓ Sell | 720 | $167.08 | $120K | Direct | Jun 4, 2019 (1d) |
| Oct 3, 2018 | VRTX | ↓ Sell | 6,818 | $192.13 | $1.3M | Direct | Oct 5, 2018 (2d) |
| Jun 4, 2018 | VRTX | ↓ Sell | 875 | $152.05 | $133K | Direct | Jun 5, 2018 (1d) |
| Jan 5, 2018 | VRTX | ↓ Sell | 10,753 | $156.00 | $1.7M | Direct | Jan 9, 2018 (4d) |
| Nov 3, 2017 | VRTX | ↓ Sell | 7,073 | $143.05 | $1.0M | Direct | Nov 7, 2017 (4d) |
| Jun 2, 2017 | VRTX | ↓ Sell | 1,176 | $128.44 | $151K | Direct | Jun 5, 2017 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other VRTX insiders
Open-market trades in the last 12 months
About Sangeeta N. Bhatia's insider trades
Sangeeta N. Bhatia is a director at Vertex Pharmaceuticals Inc / Ma (VRTX). Since Jun 2, 2017, Sangeeta has reported no open-market purchases and 27 sales worth $12.7M on SEC Form 4. In the last 12 months: 2 sales ($268K).
Their filings also include grants and awards (12 filings), option exercises (10 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VRTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.